Welcome to the e-CCO Library!

No! Surgery is the only solution!
Year: 2019
Source: 8th S-ECCO IBD Masterclass
Authors: Antonino Spinelli
Created: Wednesday, 5 June 2019, 9:01 PM
No! Surgery is the only solution!
Year: 2019
Source: 8th S-ECCO IBD Masterclass
Authors: Antonino Spinelli
Created: Tuesday, 28 May 2019, 3:32 PM
Ileo ceacal resection, Laparoscopic surgery
Files: 1
NO001: Clinical and psychological factors associated with Erectile Dysfunction in inflammatory bowel disease patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Barros J., Baima J., Renosto F., Sibia C., Silva R., Farineli E., Andriolli G., Dorna M., Saad-Hossne R., Sassaki L.

Created: Wednesday, 20 February 2019, 10:36 AM
NO001: Cognitive behavioural therapy for the management of Inflammatory Bowel Disease-fatigue: A pilot randomised controlled trial
Year: 2018
Source: 12th N-ECCO Network Meeting
Authors: Artom Micol
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
NO001: Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue: A pilot randomised controlled trial
Year: 2018
Source: 12th N-ECCO Network Meeting
Authors:

M. Artom*, W. Czuber-Dochan, J. Sturt, H. Proudfoot, C. Norton

Created: Thursday, 21 February 2019, 9:14 AM
NO002: Decision-making about emergency and planned stoma surgery for IBD: a qualitative exploration of patient and clinician perspectives
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Dibley L.*1, Czuber-Dochan W.1, Duncan J.2, Artom M.1, Burch J.3, Wade T.1, Verjee A.4, Cann D.4, Warusavitarne J.3, Norton C.1

Created: Wednesday, 20 February 2019, 10:36 AM
NO002: Increasing research capacity of IBD nurses across Europe—a case study of Inflammatory Bowel Disease Fatigue (IBD-F) scale translation and validation
Year: 2018
Source: 12th N-ECCO Network Meeting
Authors:

W. Czuber-Dochan1*, M. Artom1, C. Norton1, A. Andonova2, M. Pencova2, V. Cluzeau3, M. Chalabreysee3, R. Barkan4, I. Goren4, L. Shpoker5, S. Radice6, E. Schiavoni7, A. Cocchieri8, D. Napolitano9, L. Turchini9, M. Zega9, L.P. Jelsness-Jørgensen10, A. Giner-Agudo11, R. Barastegui11, C. Fernández-Fernández12, M. Gallego11, F. Murciano13, E. Navarro14, A. Rivera15, A. Vara-Hernández16, S. Jäghult17, K. Pihl Lesnovska17, A. der Heer-Damen18, A. Heil18, L. Moortgat19

Created: Thursday, 21 February 2019, 9:14 AM
NO002: The quality of care questionnaire – development of a valid measure for persons with Inflammatory Bowel Disease
Year: 2018
Source: 12th N-ECCO Network Meeting
Authors: Pihl Lesnovska Katarina
Created: Friday, 23 March 2018, 12:23 PM
Last Modified: Wednesday, 26 May 2021, 2:08 PM by ECCO Administrator
Files: 1
NO003: IBD nurses as integral part of a multidisciplinary IBD team: Prospective study on view on patient outcomes
Year: 2017
Source: 11th N-ECCO Network Meeting
Authors: Coenen S.
Quality of life (IBDQ), IBD nurse, Coping
Files: 1
NO003: IBD nurses as integral part of a multidisciplinary IBD team: prospective study on view on patient outcomes
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Coenen S.*1, Weyts E.1, Geens P.1, Vermeire S.1, Ferrante M.1, Noman M.1, Ballet V.1, Vanhaecht K.2, Van Assche G.1

Created: Wednesday, 20 February 2019, 10:36 AM
NO003: Increasing research capacity of IBD nurses across Europe – a case study of Inflammatory Bowel Disease Fatigue (IBD-F) scale translation and validation
Year: 2018
Source: 12th N-ECCO Network Meeting
Authors: Czuber-Dochan Wladyslawa
Created: Friday, 23 March 2018, 12:23 PM
Last Modified: Wednesday, 16 June 2021, 3:31 PM by ECCO Administrator
Files: 1
NO003: The quality of care questionnaire—development of a valid measure for persons with inflammatory bowel disease
Year: 2018
Source: 12th N-ECCO Network Meeting
Authors:

K. Pihl Lesnovska1*, S. Börjeson2, G. Hollman Frisman3, H. Hjortswang4, M. Wenemark5

Created: Thursday, 21 February 2019, 9:14 AM
Non-adherence and motivational interviewing
Year: 2019
Source: 6th P-ECCO Educational Course
Authors: Ailsa Hart
Created: Tuesday, 28 May 2019, 3:32 PM
Psychologist, Psychological co-morbidity, Adherence to therapy
Files: 1
Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (II)
Year: 2014
Source: JCC: Volume 8, Issue 1, 2014
Authors: Laurence Egan, Renata D'Inca, Tine Jess, Gianluca Pellino, Franck Carbonnel, Bernd Bokemeyer, Marcus Harbord, Paula Nunes, Janneke Van der Woude, Francesco Selvaggi, John Triantafillidis
Created: Friday, 22 February 2019, 1:47 PM by ECCO Administrator

Patients with inflammatory bowel diseases (IBD) have an excess risk of certain gastrointestinal cancers. Much work has focused on colon cancer in IBD patients, but comparatively less is known about other more rare cancers. The European Crohn's and Colitis Organization established a pathogenesis workshop to review what is known about these cancers and formulate proposals for future studies to address the most important knowledge gaps. This article reviews the current state of knowledge about small bowel adenocarcinoma, ileo-anal pouch and rectal cuff cancer, and anal/perianal fistula cancers in IBD patients.

Non-invasive assessment of intestinal inflammatory activity in Ulcerative Colitis by Multispectral Optoacoustic Tomography (MSOT)
Year: 2022
Source: ECCO'22 Virtual
Authors: Daniel Klett
Created: Tuesday, 24 May 2022, 8:13 PM
Background

In order to guide therapy in Ulcerative Colitis (UC),  repeated determination of intestinal inflammatory activity is essential. Endoscopy is the standard procedure to assess inflammation in UC. However innovative methods for non-invasive, uncomplicated and risk free estimation of inflammatory activity are needed as bowel preparation, patients discomfort and risk of procedural complications limit the (frequent) use of colonoscopy. Multispectral optoacoustic tomography (MSOT) is a promising new method to measure inflammation in UC. Using short and harmless impulses of NIR-lasers, it allows for determination of a specific hemoglobin-signal in the bowel-wall and therefore inflammatory activity in affected bowel segments. However, its informative value in UC has not been evaluated so far.

Methods

In 34 patients with confirmed UC, clinical activity parameters (e.g. clinical Mayo-Subscore, B-mode-sonography, C-reactive protein, white blood count) were collected and MSOT of the sigmoid was performed within 2 weeks before/after endoscopy. For MSOT, a commercially available clinical MSOT-system (Acuity Echo, iThera Medical, Munich) was used with sequential analysis of collected data on an external desktop PC. Finally, clinical data, ultrasound findings (Limberg) and MSOT-parameters (single wavelenghts 760 nm, 800 nm, 900 nm; multispectral signals hb, hbO2, hbT) were correlated with endoscopic findings (Mayo endoscopic Subscore, MES).

Results

We found strong and significant correlation between MES and MSOT parameters 800 nm (Spearman r = 0,6599; p < 0,0001) and HbO2 (Spearman r = 0,6695; p < 0,0001), superior to sonographic evaluation of the inflammatory activity in affected bowel segments (Spearman r = 0,4914; p = 0,0023) . Simultaneously these MSOT parameters demonstrated excellent sensitivity and specifity in distinguishing moderately to highly active (MES 2,3) from inactive and mild disease (MES 0,1) (800nm: AUROC 0,9063 (p < 0,0001); sensitivity = 93,75 %, specificity = 88,89 %; HbO2: AUROC 0,9063 (p < 0,0001); sensitivity = 100 %, specificity = 88,89 %).

Conclusion

MSOT is a promising approach to non-invasively assess intestinal inflammation in UC and therefore monitor anti-inflammatory therapy in these patients. Further studies are required to validate these findings.

Non-neoplastic complications of IBD
Year: 2022
Source: 7th H-ECCO IBD Masterclass
Authors: Francesca Rosini
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content

Inflammatory bowel diseases may lead to many non-neoplastic intestinal and extra-intestinal problems. 
The main intestinal complications comprise infections, obstruction, perforation fistulas etc, whereas the main extra-intestinal manifestations include skin conditions, liver and biliary diseases, eye complications, systemic infections and other systemic conditions.

Learning objectives: 
- which are the main non-neoplastic intestinal complications
- which are the main non-neoplastic extra-intestinal complications
- example and presentation of interesting histological cases

Non-Pharmacological Interventions in IBD
Year: 2019
Source: Educational Audio Podcasts
Authors: Ailsa Hart
Created: Friday, 28 February 2020, 3:58 PM by Dauren Ramankulov
Last Modified: Friday, 13 January 2023, 12:24 PM by ECCO Administrator
Non-pharmacological strategies: Ready for primetime?
Year: 2022
Source: 8th ClinCom Workshop
Authors: James Lindsay
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content

Discussion of non pharmacological strategies to maintain remission
Review of evidence for dietary intervention
Pre and probiotic therapy
Complementary therapies
Modifying the faecal microbiota
Techniques to modify stress
Vagal nerve stimulation

Nonepithelial neoplasia in IBD
Year: 2021
Source: 6th H-ECCO IBD Masterclass
Authors: Pamela Baldin
Created: Friday, 1 October 2021, 12:41 PM
Summary content

An increased rate of non epithelial neoplasm in IBD is described. They could be related to inflammation or to immunosuppressive treatment. The increased risk of infection related lymphomas in IBD is debated. Concerning non epithelial neoplasm related to immunosuppressive treatment they are mainly lymphomas, skin tumours and Kaposi’s sarcomas.

The main educational objective is to know and to  be aware about the presence of this rare entities.